Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)

Margaret Camilla Watson, Christine Margaret Bond, Grampian Evidence Based Comm

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

In the UK, there has been a rapid increase in the reclassification of prescription only medicines ( POMs) to pharmacy only ( P) and general sales list (GSL) status. This means that community pharmacy staff have a greater range of non-prescription medicines to recommend for the treatment of minor illness. Strategies are needed to promote good professional practice in the supply of non-prescription medicines. Guidelines have been shown to promote quality of care in other health care settings. In this article, we present evidence based guidelines for the treatment of vulvovaginal candidiasis using non-prescription anti-fungal medicines.

Original languageEnglish
Pages (from-to)129-134
Number of pages5
JournalPharmacy World and Science
Volume25
Issue number4
DOIs
Publication statusPublished - 2003

Keywords

  • community pharmacy
  • evidence-based practice
  • guidelines
  • vulvovaginal candidiasis
  • OVER-THE-COUNTER
  • CLINICAL MANIFESTATIONS
  • SYMPTOMS
  • DIAGNOSIS
  • WOMEN
  • PHARMACISTS
  • MANAGEMENT
  • INFECTIONS
  • YEAST
  • SIGNS

Fingerprint

Dive into the research topics of 'Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)'. Together they form a unique fingerprint.

Cite this